IFNγ from CD8+ T cells and arachidonic acid (AA) from the tumor microenvironment mediate tumorigenic ferroptosis through acyl-CoA synthetase long-chain family member 4 (ACSL4) while targeting tumor ACSL4 reportedly improved immune checkpoint blockade treatment sensitivity (26). Here, ACSL4 is linked to neoplasm.